CONDOR randomized 689 adults with type 1/2 diabetes and PRP-naïve PDR across 152 sites in 16 countries; 572 completed the week-54 visit. Brolucizumab was administered q6w for three doses then q12w, ...

Data collected from a number of clinical trials found that despite recent “buzz,” there is no significant link between GLP-1 receptor agonists and the progression of diabetic retinopathy, according to ...

Blood glucose levels can be a reliable indicator of diabetes risk. But in some populations, it's not enough to catch the disease early. Globally, diabetes has become one of the defining health crises ...

For ten years, the Fr1da study, coordinated by Helmholtz Munich, has been investigating whether early stages of type 1 ...

In recognition of National School Nurse Day on May 6, 2026, Shara Bialo, MD, senior medical director, Sanofi, discusses the unique position school nurses play in early diabetes detection in a ...

When a clinician prescribes a medication for a purpose for which it’s not indicated by the U.S. Food and Drug Administration (FDA), it’s referred to as off-label treatment. Doctors may recommend ...

Smoking, vaping, or using both products significantly increases the likelihood of developing prediabetes and diabetes, and the risk is even higher among Hispanic, Black, and low-income groups.

In people with epilepsy, a new study has found a smartwatch application accurately detected tonic-clonic seizures, seizures ...

Diabetes knows no age limit, making regular blood sugar checks essential for prompt medical intervention. Diabetes Malaysia (Tanjung Puteri branch) president Datuk Tan Poi Chung warned that the ...